Cart
sales@molnova.com
Epcoritamab
CAS No. 2134641-34-0
Epcoritamab( —— )
Catalog No. M37173 CAS No. 2134641-34-0
Epcoritamab (GEN3013) is a novel subcutaneous CD3xCD20 bispecific T-cell binding antibody that activates T-cells and directs them to kill malignant CD20(+) B-cells for the study of relapsed or refractory large B-cell lymphoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 818 | Get Quote |
|
| 5MG | 1311 | Get Quote |
|
| 10MG | 2138 | Get Quote |
|
| 25MG | 3082 | Get Quote |
|
| 50MG | 4158 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEpcoritamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpcoritamab (GEN3013) is a novel subcutaneous CD3xCD20 bispecific T-cell binding antibody that activates T-cells and directs them to kill malignant CD20(+) B-cells for the study of relapsed or refractory large B-cell lymphoma.
-
DescriptionEpcoritamab (GEN3013) is an bispecific IgG1 antibody redirecting T-cells toward CD3×CD20+ tumor cells. Epcoritamab induces potent T-cell-mediated cytotoxicity towards B-cell NHL cell lines.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2134641-34-0
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. van der Horst HJ, et al. Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment. Blood Cancer J. 2021 Feb 18;11(2):38. ?
molnova catalog
related products
-
Caffeoylcalleryanin
Caffeoylcalleryanin exerted strong 15-LOX inhibitory activity; IC50 values was 1.59 μM.A. pulchra leaves ethanol extract (EEAPL) affords compounds with antiviral activity, mainly against DENV-2. respectively, while Caffeoylcalleryanin was the most effective anti-DENV-2 constituent, with a SI of 20.0.
-
Triphenyl bismuth
Triphenyl bismuth is an additive for making biomedical resins visible on x-ray images and can be used as a radiopaque agent for orthopaedic bone cements.
-
Halofuginone hydrobr...
Halofuginone specifically inhibits collagen type I gene expression and matrix metalloproteinase 2 (MMP-2) gene expression, which may result in the suppression of angiogenesis, tumor stromal cell development, and tumor cell growth.
